CELLECTAR BIOSCIENCES INC. - Weekly - Technical analysis published on 05/03/2024 (GMT)
- 100
- 0
- Timeframe : Weekly
- - Analysis generated on
- Status : IN PROGRESS...
Summary of the analysis
Trends
Short term:
Bullish
Underlying:
Slightly bullish
Technical indicators
22%
33%
44%
My opinion
Bullish above
My targets
()
()
My analysis
The bullish trend is truly tentative and does not seem to be supported in the short term. It is advisable to trade CELLECTAR BIOSCIENCES INC. with the greatest caution, while favouring long positions (at the time of purchase) as long as the price remains well above . The buyers' bullish objective is set at . A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at . If there is any crossing, the next objective would be the resistance located at . If there is a bearish break in the support located at some indecision would arise.
In the very short term, the general bullish sentiment is not called into question, despite technical indicators being indecisive.
Force
0
10
1.1
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by ppires. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
CELLECTAR BIOSCIENCES INC. rating 3.45 USD. The price is up +13.86% over 5 days and was traded between 3.03 USD and 3.51 USD over the period. The price is currently at +14.05% from its lowest point and -1.71% from its highest point.3.03
3.51
3.45
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of CELLECTAR BIOSCIENCES INC. in Weekly shows an overall slightly bullish trend. Only 50.00% of the signals given by moving averages are bullish. This slightly bullish trend is not supported by the signals currently being given by short-term moving averages. An assessment of moving averages reveals a bullish signal that could impact this trend:
Bullish price crossover with adaptative moving average 20
Type : Bullish
Timeframe : Weekly
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Central Indicators, the scanner specialised in technical indicators, has identified these signals:
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Weekly
RSI indicator is back over 50
Type : Bullish
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S1
R1
R2
R3
Price
S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|
ProTrendLines | 1.95 | 3.45 | 4.29 | 10.60 | 18.12 |
Change (%) | -43.48% | - | +24.35% | +207.25% | +425.22% |
Change | -1.50 | - | +0.84 | +7.15 | +14.67 |
Level | Major | - | Intermediate | Minor | Minor |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 3.10 | 3.17 | 3.26 | 3.33 | 3.42 | 3.49 | 3.58 |
Camarilla | 3.30 | 3.31 | 3.33 | 3.34 | 3.36 | 3.37 | 3.38 |
Woodie | 3.10 | 3.18 | 3.26 | 3.34 | 3.42 | 3.50 | 3.58 |
Fibonacci | 3.17 | 3.23 | 3.27 | 3.33 | 3.39 | 3.43 | 3.49 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.55 | 2.74 | 2.89 | 3.08 | 3.23 | 3.42 | 3.57 |
Camarilla | 2.94 | 2.97 | 3.00 | 3.03 | 3.06 | 3.09 | 3.12 |
Woodie | 2.52 | 2.73 | 2.86 | 3.07 | 3.20 | 3.41 | 3.54 |
Fibonacci | 2.74 | 2.87 | 2.95 | 3.08 | 3.21 | 3.29 | 3.42 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 1.43 | 2.18 | 2.64 | 3.39 | 3.85 | 4.60 | 5.06 |
Camarilla | 2.76 | 2.87 | 2.98 | 3.09 | 3.20 | 3.31 | 3.42 |
Woodie | 1.28 | 2.11 | 2.49 | 3.32 | 3.70 | 4.53 | 4.91 |
Fibonacci | 2.18 | 2.65 | 2.93 | 3.39 | 3.86 | 4.14 | 4.60 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
RSI (14): | 51.94 | |
MACD (12,26,9): | 0.2100 | |
Directional Movement: | 5.03 | |
AROON (14): | -50.00 | |
DEMA (21): | 3.67 | |
Parabolic SAR (0,02-0,02-0,2): | 4.23 | |
Elder Ray (13): | -0.21 | |
Super Trend (3,10): | 2.70 | |
Zig ZAG (10): | 3.34 | |
VORTEX (21): | 1.0300 | |
Stochastique (14,3,5): | 11.28 | |
TEMA (21): | 3.61 | |
Williams %R (14): | -73.51 | |
Chande Momentum Oscillator (20): | -0.16 | |
Repulse (5,40,3): | -5.2000 | |
ROCnROLL: | -1 | |
TRIX (15,9): | 1.7300 | |
Courbe Coppock: | 19.68 |
MA7: | 3.11 | |
MA20: | 3.30 | |
MA50: | 3.60 | |
MA100: | 3.41 | |
MAexp7: | 3.40 | |
MAexp20: | 3.33 | |
MAexp50: | 3.00 | |
MAexp100: | 3.81 | |
Price / MA7: | +10.93% | |
Price / MA20: | +4.55% | |
Price / MA50: | -4.17% | |
Price / MA100: | +1.17% | |
Price / MAexp7: | +1.47% | |
Price / MAexp20: | +3.60% | |
Price / MAexp50: | +15.00% | |
Price / MAexp100: | -9.45% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
Don't forget to follow the news on CELLECTAR BIOSCIENCES INC.. At the time of publication of this analysis, the latest news was as follows:
- Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update
- Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024
- Cellectar Biosciences to Present at the 36th Annual Roth Conference
- Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
- Thinking about buying stock in TOP Financial Group, Macy's, MicroCloud Hologram, Cellectar Biosciences, or New York Community Bancorp?
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis CELLECTAR BIOSCIENCES INC. - Weekly